• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泛素特异性蛋白酶7去泛素化并调节极光激酶B介导的胞质分裂。

Ubiquitin specific protease 7 deubiquitinates and regulates Aurora B-mediated cytokinesis.

作者信息

Kaushal Kamini, Antao Ainsley Mike, Das Soumyadip, Kim Sammy L, Birappa Girish, Rajkumar Sripriya, Gowda D A Ayush, Ajaykumar C Bindu, Singh Vijai, Kim Keesung, Suresh Bharathi, Ramakrishna Suresh

机构信息

Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul 04763, Korea.

Department of Biological Sciences, College of Sang-Huh Life Science, Konkuk University, Seoul 05029, Korea.

出版信息

BMB Rep. 2025 Aug;58(8):350-356. doi: 10.5483/BMBRep.2024-0154.

DOI:10.5483/BMBRep.2024-0154
PMID:40754775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12402693/
Abstract

Aurora B is a widely studied mitotic checkpoint kinase that forms a part of the chromosomal passenger complex. The entry to and exit from mitosis are exquisitely controlled by Aurora B proteins, which regulate mitotic phases including chromosomal condensation, segregation, and cytokinesis, ensuring faithful propagation of daughter cells. Abnormal regulation of Aurora B proteins during the cell cycle can cause increased chromosomal segregation errors and ultimately lead to cancer. Thus, it is important to understand the key mechanisms that can modulate Aurora B protein levels during the cell cycle. Therefore, in this study we demonstrated the role of Ubiquitin-specific protease 7 (USP7) in regulating Aurora B protein level. Aurora B protein levels are upregulated when USP7 is dose-dependently increased, and downregulated when USP7 is depleted. By co-immunoprecipitation and Duolink assays, we demonstrated that USP7 interact with Aurora B. Furthermore, by treating cycloheximide we showed that USP7 extends the Aurora B protein half-life by its deubiquitinating activity. Finally, CRISPR/Cas9-mediated USP7 knockout produces severe nuclear structural defects causing multi-nucleation and cytokinesis failures, suggesting that the important role of USP7 during mitotic progression in stabilizing Aurora B. [BMB Reports 2025; 58(8): 350-356].

摘要

极光激酶B(Aurora B)是一种被广泛研究的有丝分裂检查点激酶,它是染色体乘客复合体的一部分。有丝分裂的进入和退出由极光激酶B蛋白精确控制,该蛋白调节有丝分裂阶段,包括染色体凝聚、分离和胞质分裂,确保子细胞的忠实增殖。细胞周期中极光激酶B蛋白的异常调节会导致染色体分离错误增加,最终导致癌症。因此,了解在细胞周期中可以调节极光激酶B蛋白水平的关键机制非常重要。因此,在本研究中,我们证明了泛素特异性蛋白酶7(USP7)在调节极光激酶B蛋白水平中的作用。当USP7剂量依赖性增加时,极光激酶B蛋白水平上调,而当USP7缺失时则下调。通过免疫共沉淀和Duolink检测,我们证明了USP7与极光激酶B相互作用。此外,通过用放线菌酮处理,我们表明USP7通过其去泛素化活性延长了极光激酶B蛋白的半衰期。最后,CRISPR/Cas9介导的USP7基因敲除产生严重的核结构缺陷,导致多核化和胞质分裂失败,这表明USP7在有丝分裂进程中对稳定极光激酶B具有重要作用。[《BMB报告》2025年;58(8): 350 - 356]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79cb/12402693/a24444769976/bmb-58-8-350-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79cb/12402693/0feb21856c7e/bmb-58-8-350-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79cb/12402693/6f253a71ce97/bmb-58-8-350-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79cb/12402693/1be32a418ca1/bmb-58-8-350-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79cb/12402693/a24444769976/bmb-58-8-350-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79cb/12402693/0feb21856c7e/bmb-58-8-350-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79cb/12402693/6f253a71ce97/bmb-58-8-350-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79cb/12402693/1be32a418ca1/bmb-58-8-350-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79cb/12402693/a24444769976/bmb-58-8-350-f4.jpg

相似文献

1
Ubiquitin specific protease 7 deubiquitinates and regulates Aurora B-mediated cytokinesis.泛素特异性蛋白酶7去泛素化并调节极光激酶B介导的胞质分裂。
BMB Rep. 2025 Aug;58(8):350-356. doi: 10.5483/BMBRep.2024-0154.
2
USP48 Governs Cell Cycle Progression by Regulating the Protein Level of Aurora B.USP48 通过调节 Aurora B 的蛋白水平来控制细胞周期进程。
Int J Mol Sci. 2021 Aug 7;22(16):8508. doi: 10.3390/ijms22168508.
3
Aurora-C kinase supports mitotic progression in the absence of Aurora-B.在没有极光激酶B的情况下,极光激酶C支持有丝分裂进程。
Cell Cycle. 2009 Sep 15;8(18):2984-94. Epub 2009 Sep 21.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
TIP60 acetylation of Bub1 regulates centromeric H2AT120 phosphorylation for faithful chromosome segregation.TIP60 对 Bub1 的乙酰化调控着着丝粒区 H2AT120 的磷酸化,以保证染色体的正确分离。
Sci China Life Sci. 2024 Sep;67(9):1957-1969. doi: 10.1007/s11427-023-2604-8. Epub 2024 May 17.
6
MLKL-USP7-UBA52 signaling is indispensable for autophagy in brain through maintaining ubiquitin homeostasis.MLKL-USP7-UBA52信号通路通过维持泛素稳态对大脑中的自噬不可或缺。
Autophagy. 2025 Feb;21(2):424-446. doi: 10.1080/15548627.2024.2395727. Epub 2024 Sep 19.
7
Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis.泛素特异性蛋白酶 7 维持 DNA 损伤反应并促进宫颈癌发生。
J Clin Invest. 2018 Oct 1;128(10):4280-4296. doi: 10.1172/JCI120518. Epub 2018 Sep 4.
8
Aurora B kinase: a potential drug target for cancer therapy.极光激酶 B:癌症治疗的潜在药物靶点。
J Cancer Res Clin Oncol. 2021 Aug;147(8):2187-2198. doi: 10.1007/s00432-021-03669-5. Epub 2021 May 28.
9
Inhibition of USP7 enhances CD8 T cell activity in liver cancer by suppressing PRDM1-mediated FGL1 upregulation.USP7 抑制通过抑制 PRDM1 介导的 FGL1 上调增强肝癌中 CD8 T 细胞的活性。
Acta Pharmacol Sin. 2024 Aug;45(8):1686-1700. doi: 10.1038/s41401-024-01263-2. Epub 2024 Apr 8.
10
Therapeutic targeting of ubiquitin-specific protease 7 (USP7): Mechanistic insights, dysregulation, and advances in drug discovery.泛素特异性蛋白酶7(USP7)的治疗靶点:作用机制见解、失调及药物发现进展
Eur J Med Chem. 2025 Oct 15;296:117872. doi: 10.1016/j.ejmech.2025.117872. Epub 2025 Jun 18.

本文引用的文献

1
CRISPR/Cas9-based genome-wide screening of the deubiquitinase subfamily identifies USP3 as a protein stabilizer of REST blocking neuronal differentiation and promotes neuroblastoma tumorigenesis.基于 CRISPR/Cas9 的全基因组去泛素化酶亚家族筛选鉴定 USP3 为 REST 阻断神经元分化的蛋白质稳定剂,并促进神经母细胞瘤的肿瘤发生。
J Exp Clin Cancer Res. 2023 May 12;42(1):121. doi: 10.1186/s13046-023-02694-1.
2
CRISPR/Cas9-based genome-wide screening for deubiquitinase subfamily identifies USP1 regulating MAST1-driven cisplatin-resistance in cancer cells.基于 CRISPR/Cas9 的全基因组筛选鉴定去泛素化酶亚家族 USP1 调控 MAST1 驱动的癌细胞顺铂耐药性。
Theranostics. 2022 Aug 8;12(13):5949-5970. doi: 10.7150/thno.72826. eCollection 2022.
3
Dual role of deubiquitinating enzyme USP19 regulates mitotic progression and tumorigenesis by stabilizing survivin.去泛素化酶 USP19 通过稳定 survivin 发挥双重作用,调节有丝分裂进程和肿瘤发生。
Mol Ther. 2022 Nov 2;30(11):3414-3429. doi: 10.1016/j.ymthe.2022.07.019. Epub 2022 Aug 1.
4
Deubiquitinase USP19 enhances phenylalanine hydroxylase protein stability and its enzymatic activity.去泛素化酶USP19增强苯丙氨酸羟化酶的蛋白质稳定性及其酶活性。
Cell Biol Toxicol. 2023 Oct;39(5):2295-2310. doi: 10.1007/s10565-022-09719-z. Epub 2022 Apr 21.
5
Genome-wide screening for deubiquitinase subfamily identifies ubiquitin-specific protease 49 as a novel regulator of odontogenesis.全基因组筛选去泛素化酶亚家族发现泛素特异性蛋白酶 49 是牙发生的一个新的调节因子。
Cell Death Differ. 2022 Sep;29(9):1689-1704. doi: 10.1038/s41418-022-00956-7. Epub 2022 Mar 10.
6
USP32 confers cancer cell resistance to YM155 via promoting ER-associated degradation of solute carrier protein SLC35F2.USP32 通过促进溶质载体蛋白 SLC35F2 的 ER 相关降解赋予癌细胞对 YM155 的耐药性。
Theranostics. 2021 Sep 27;11(20):9752-9771. doi: 10.7150/thno.63806. eCollection 2021.
7
CYLD destabilizes NoxO1 protein by promoting ubiquitination and regulates prostate cancer progression.CYLD 通过促进泛素化来破坏 NoxO1 蛋白,从而调节前列腺癌的进展。
Cancer Lett. 2022 Jan 28;525:146-157. doi: 10.1016/j.canlet.2021.10.032. Epub 2021 Nov 3.
8
USP48 Governs Cell Cycle Progression by Regulating the Protein Level of Aurora B.USP48 通过调节 Aurora B 的蛋白水平来控制细胞周期进程。
Int J Mol Sci. 2021 Aug 7;22(16):8508. doi: 10.3390/ijms22168508.
9
USP7 limits CDK1 activity throughout the cell cycle.USP7 限制细胞周期内 CDK1 的活性。
EMBO J. 2021 Jun 1;40(11):e99692. doi: 10.15252/embj.201899692. Epub 2021 Apr 15.
10
HAUSP stabilizes Cdc25A and protects cervical cancer cells from DNA damage response.HAUSP 稳定 Cdc25A 并保护宫颈癌细胞免受 DNA 损伤反应。
Biochim Biophys Acta Mol Cell Res. 2020 Dec;1867(12):118835. doi: 10.1016/j.bbamcr.2020.118835. Epub 2020 Aug 27.